Recent Updates
Recently added Catalysts
ATHE Positive Sentiment Score: 68/100

Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities Announcement Summary Entity name ALTERITY THERAPEUTICS LIMITED Date of this announcement Thursday

Key Takeaway: Alterity Therapeutics Limited has announced the issuance of 18 million unlisted options as part of an employee incentive scheme, with an exercise price of $0.008 and an expiry date of January 9, 2031. This issuance is not intended to be quoted on the ASX and reflects the company’s strategy to motivate and retain key personnel. The announcement underscores the company's ongoing initiatives to enhance its financial framework through equity incentives.

Market Sentiment Analysis

POSITIVE FACTORS

  • Issuance of 18 million unlisted options shows confidence in employee incentives.
  • Options have a long expiry date until January 20231, providing a long-term incentive.
  • The capital raise can enhance the company’s financial stability.

Full Press Release Details

Announcement Summary
ALTERITY THERAPEUTICS LIMITED
Date of this announcement
Thursday January 15, 2026
The +securities the subject of this notification are:
+Other securities issued under an +employee incentive scheme
that are not intended to be quoted on ASX
Total number of +securities to be issued/transferred
ASX +security code Security description Total number of +securities to be issued/transferred Issue date
New class - code to be confirmed Unlisted options expiring 9 January 2031 ex $0.008 18,000,000 15/01/2026
Refer to next page for full details of the announcement
Part 1 - Entity and announcement details
1.1 Name of entity
ALTERITY THERAPEUTICS LIMITED
We (the entity named above) give notice of the issue, conversion or payment up of the following unquoted +securities.
1.2 Registered number type Registration number
ABN 37080699065
1.3 ASX issuer code
ATH
1.4 The announcement is
New announcement
1.5 Date of this announcement
15/1/2026
Part 2 - Issue details
2.1 The +securities the subject of this notification are:
+Other securities issued under an +employee incentive scheme
that are not intended to be quoted on ASX
2.2a This notification is given in relation to an issue
of +securities in a class which is not quoted on ASX and which:
does not have an existing ASX security code ("new class")
Part 3C - number and type of +securities the subject of this notification
ASX +security code +Security description
New class - code to be confirmed Unlisted options expiring 9 January 2031 ex $0.008
+Security type ISIN code
Options
Date the +securities the subject of this notification
Will all the +securities issued in this class rank equally
in all respects from their issue date?
Were any of the +securities issued to +key management
personnel (KMP) or an +associate?
Have you received confirmation from ASX that the terms
of the +securities are appropriate and equitable under listing rule 6.1?
Please provide a URL link for a document lodged with
ASX setting out the material terms of the +securities being issued.
+Security currency Exercise price Expiry date
AUD - Australian Dollar AUD 0.00800000 9/1/2031
Details of the existing class of +security that will
be issued upon exercise or conversion of this new class of company option
ATH : ORDINARY FULLY PAID
Please provide a URL link for a document lodged with
ASX detailing the terms of the +employee incentive scheme or a summary of the terms
Any other information the entity wishes to provide about
the +securities the subject of this notification
Number of +securities
4 - +Securities on issue
Following the issue, conversion or payment up of the
+securities the subject of this notification, the +securities of the entity will comprise:
The figures in parts 4.1 and 4.2 below are automatically
generated and may not reflect the entity's current issued capital if other Appendix 2A, Appendix 3G or Appendix 3H forms are currently
with ASX for processing.
4.1 Quoted +securities (Total number of each +class of
+securities issued and quoted on ASX)
Total number of
ASX +security code and description +securities on issue
ATH : ORDINARY FULLY PAID 10,875,416,329
ATHO : OPTION EXPIRING 31-AUG-2026 931,232,089
ATHOA : OPTION EXPIRING 26-FEB-2027 1,222,300,911
4.2 Unquoted +securities (Total number of each +class
of +securities issued but not quoted on ASX)
Total number of
ASX +security code and description +securities on issue
ATHAAE : OPTION EXPIRING 29-NOV-2026 EX $0.0375 10,000,000
ATHAAG : OPTION EXPIRING 29-NOV-2026 EX $0.0238 11,500,000
ATHAE : OPTION EXPIRING 08-AUG-2030 EX $0.013 11,500,000
ATHAF : OPTION EXPIRING 08-AUG-2030 EX USD 0.0086 312,400,200
ATHAD : OPTION EXPIRING 01-JUL-2030 EX $0.01 15,000,000
ATHAAK : OPTION EXPIRING 30-DEC-2027 EX $0.01 170,000,000
ATHAAH : OPTION EXPIRING 19-DEC-2026 EX $0.0105 8,000,000
ATHAB : OPTION EXPIRING 13-MAR-2029 EX US$0.0031 62,500,000
ATHAA : OPTION EXPIRING 13-MAR-2029 EX $0.004 20,166,667
ATHAC : OPTION EXPIRING 21-MAR-2029 EX US$0.003 40,000,200
New class - code to be confirmed : Unlisted options expiring 9 January 2031 ex $0.008 18,000,000
Part 5 - Other Listing Rule requirements
5.1 Were the +securities issued under an exception in
Listing Rule 7.2 and therefore the issue did not need any security holder approval under Listing Rule 7.1?
5.1a Select the number of the applicable exception in

Frequently Asked Questions

What is the announcement date for Alterity Therapeutics?

The announcement date is January 15, 2026.

What type of securities are being issued?

Unlisted options expiring on January 9, 2031, are being issued.

How many new options will be issued?

A total of 18,000,000 unlisted options will be issued.

What is the exercise price for the new options?

The exercise price for the new options is AUD $0.008.

Will the new securities rank equally with existing ones?

Yes, all new securities will rank equally from their issue date.

Last updated: Jan 15, 2026